|1||NCT02295475||Recruiting||Apixaban for the Secondary Prevention of Thromboembolism Among Patients With the AntiphosPholipid Syndrome||
||Other / Industry||
||200||All||18 Years and older (Adult, Senior)||NCT02295475||CV185-357||ASTRO-APS||February 2015||December 2019||December 2019||November 20, 2014||June 23, 2017||
|2||NCT01088334||Terminated||Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism||
||630||All||40 Years and older (Adult, Senior)||NCT01088334||Trousseau studie||Trousseau||December 2002||May 2008||December 2008||March 17, 2010||March 29, 2010||
|3||NCT00000566||Completed||Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)||
||All||18 Years to 75 Years (Adult, Senior)||NCT00000566||204||September 1983||December 1989||October 28, 1999||April 15, 2016|
† Study has passed its completion date and status has not been verified in more than two years.